AMTI

SVB Securities analyst Joseph Schwartz maintained a Buy rating on Applied Molecular Transport (AMTI - Research Report) on November 7 and set a price target of $15.00. The company's shares closed yesterday at $0.93.According to TipRanks, Schwartz is an analyst with an average return of -17.9% and a 30.77% success rate. Schwartz covers the Healthcare sector, focusing on stocks such as BioMarin Pharmaceutical, Travere Therapeutics, and Ascendis Pharma.Currently, the analyst consensus on Applied Molecular Transport is a Moderate Buy with an average price target of $21.00, a 2,170.27% upside from current levels.
https://www.tipranks.com/news/blurbs/svb-securities-remains-a-buy-on-applied-molecular-transport-amti?utm_source=advfn.com&utm_medium=referral